Claims
- 1. A compound of formula (I) or a pharmaceutically acceptable acid addition salt of said compound having a basic nitrogen atom: ##STR35## wherein R is hydrogen, methyl or phenyl; R.sub.a, R.sub.b, R.sub.c and R.sub.d are selected from hydrogen, lower alkyl, lower alkoxy, halo and nitro; R.sup.1 is an antibacterially active penicillin-completing side chain selected from phenylacetamido, p-hydroxyphenylacetamido; p-heptylphenylacetamido; phenoxyacetamido; .alpha.-phenoxypropionamido; .alpha.-phenoxybutyramido; 2,6-dimethoxyphenylacetamido; 3-phenyl-5-methyl-isoxazole-4-carbamido; 3-(2-chlorophenyl)-5-methyl-isoxazole-4-carbamido; 3-(2,6-dichlorophenyl)-5-methyl-isoxazole-4-carbamido; 3-(2-chloro-6-fluorophenyl)-5-methyl-isoxazole-4-carbamido; 2-ethoxy-naphthyl-1-carbamido; o, m or p-aminophenylacetamido; 3-carboxy-quinoxalin-2-carbamido; 2-furylacetamido; 2-thienylacetamido; 3-thienylacetamido; 3-pyridylacetamido; isothiazolylacetamido; 3-hexenamide; 2-biphenylamido; n-hexanamido; n-octanamido; propionamido; .alpha.-aminophenylacetamido; .alpha.-amino-2-thienylacetamido; .alpha. -amino-3-thienylacetamido; .alpha.-methyl-aminophenylacetamido; .alpha.-amino-2- or -3- or -4-chlorophenylacetamido; .alpha.-amino-2-methoxy-phenylacetamido; .alpha. -amino-2,4-dichlorophenylacetamido; .alpha. -amino-3,4-dichlorophenylacetamido; .alpha. -amino-.alpha. -methylphenylacetamido; .alpha.-amino-4-hydroxyphenylacetamido; .alpha.-amino-3-chloro-4-hydroxy-phenylacetamido; .alpha.-methylphenylacetamido; .alpha.-hydroxyphenylacetamido; .alpha.-carboxyphenylacetamido; .alpha.-(5-tetrazolyl)phenylacetamido; .alpha.-guanidino-2-thienylacetamido; .alpha.-guanidino-4-hydroxyphenylacetamido .alpha.-guanidino-4-hydroxy-2- or -3-methylphenylacetamido; .alpha.-carboxy-3-thienylacetamido; .alpha.-sulphaminophenylacetamido; .alpha.-sulphamino- 3-thienylacetamido; .alpha.-(N-methylsulphamino)-phenylacetamido; .alpha.-azidophenylacetamido; 1-aminocyclohexylcarbamido; 1-aminocyclopentylcarbamido; 5-amino-5-carboxypentanamido; .alpha.-phenoxyphenylacetamido; .alpha. -phenyl-.beta.-sulphaminopropionamido; .alpha.-sulphophenylacetamido; .alpha.-guanidinophenylacetamido; .beta.-amino-.beta.-cyclohexylpropionamido; .alpha.-(benzyloxycarbonyl)-phenylacetamido; or 2,2-dimethyl-5-oxo-4-phenyl-1-imidazolidinyl, (hexahydro-1H-azepin-1-yl)methyleneamino or N,N-dimethylformamidino, provided that when R is hydrogen and R.sup.1 is D-.alpha.-aminophenylacetamido R.sub.a, R.sub.b, R.sub.c and R.sub.d are not all hydrogen.
- 2. The compound of claim 1 which is 5,6-dimethoxyphthalide 6[D(-).alpha.-aminophenylacetamido] penicillanate or a pharmaceutically acceptable non-toxic acid addition salt thereof.
- 3. A compound of claim 1 wherein R.sup.1 is phenylacetamido.
- 4. A compound of claim 1 wherein R.sup.1 is phenoxymethylacetamido.
- 5. A compound of claim 1 wherein R.sup.1 is .alpha.-aminophenylacetamido.
- 6. A compound of claim 1 wherein R.sup.1 is .alpha.-guanidino-p-hydroxyphenylacetamido.
- 7. A compound of claim 1 wherein R.sup.1 is .alpha.-carboxyphenylacetamido.
- 8. A compound of claim 1 wherein R.sup.1 is .alpha.-azidophenylacetamido.
- 9. The compound of claim 1 which is 6-methoxyphthalide 6[D(-).alpha.-aminophenylacetamido] penicillanate or a pharmaceutically acceptable acid addition salt thereof.
- 10. The compound of claim 1 which is 6-chlorophthalide 6[D(-).alpha.-aminophenylacetamido] penicillanate or a pharmaceutically acceptable acid addition salt thereof.
- 11. The compound of claim 1 which is 4,5,6-trimethoxyphthalide 6[D(-).alpha.-aminophenylacetamido] penicillanate or a pharmaceutically acceptable acid addition salt thereof.
- 12. The compound of claim 1 which is 6-bromophthalide 6[D(-).alpha.-aminophenylacetamido] penicillanate or a pharmaceutically acceptable acid addition salt thereof.
- 13. The compound of claim 1 which is 3-methylphthalide 6[D(-).alpha.-aminophenylacetamido] penicillanate or a pharmaceutically acceptable acid addition salt thereof.
- 14. The compound of claim 1 which is phthalide 6[D(-).alpha.-amino-3-thienylacetamido] penicillanate or a pharmaceutically acceptable acid addition salt thereof.
- 15. The compound of claim 1 which is 5,6-dimethoxyphthalide 6[D,L-.alpha.-amino-3-thienylacetamido] penicillanate or a pharmaceutically acceptable acid addition salt thereof.
- 16. The compound of claim 1 which is 6-nitrophthalide 6[phenylacetamido] penicillanate.
- 17. The compound of claim 1 which is 5,6-dimethylphthalide 6[phenylacetamido] penicillanate.
- 18. The compound of claim 1 which is 6-methoxyphthalide 6[phenylacetamido] penicillanate.
- 19. The compound of claim 1 which is 3-phenylphthalide 6[phenylacetamido] penicillanate.
- 20. The compound of claim 1 which is 3-methylphthalide 6[phenylacetamido] penicillanate.
- 21. The compound of claim 1 which is 3-methylphthalide 6[phenoxyacetamido] penicillanate.
- 22. The compound of claim 1 which is 3-phenylphthalide 6[phenoxyacetamido] penicillanate.
- 23. The compound of claim 1 which is phthalide 6[D(-).alpha.-guanidino-p-hydroxyphenylacetamido] penicillanate or a pharmaceutically acceptable acid addition salt thereof.
- 24. The compound of claim 1 which is phthalide 6[.alpha.-guanidino-4-hydroxy-3-methylphenylacetamido] penicillanate or a pharmaceutically acceptable acid addition salt thereof.
- 25. The compound of claim 1 which is phthalide 6[.alpha.-guanidino-4-hydroxy-2-methylphenylacetamido] penicillanate or a pharmaceutically acceptable acid addition salt thereof.
- 26. The compound of claim 1 which is phthalide 6[.alpha.-sulpho-phenylacetamido] penicillanate or a pharmaceutically acceptable acid addition salt thereof.
- 27. The compound of claim 1 which is phthalide 6[.alpha.-carboxy-phenylacetamido] penicillanate or a pharmaceutically acceptable acid addition salt thereof.
- 28. The compound of claim 1 which is .alpha., .beta.-bis-phthalide 6[.alpha.-carboxyphenylacetamido]penicillanate.
- 29. The compound of claim 1 which is .alpha., .beta.-bis-phthalide 6[.alpha.-carboxy-3-thienylacetamido]penicillanate.
- 30. The compound of claim 1 which is .alpha.-sulphophenylacetamido.
- 31. Phthalide 6[.alpha.-azido-phenylacetamido] penicillanate.
- 32. Phthalide 6[.beta.-amino-.beta.-cyclohex-3-enyl-propionamido] penicillanate or a pharmaceutically acceptable acid addition salt thereof;
- 33. Phthalide 6[-(3-o-chlorophenyl-5-methyl-isoxazole-4-carbamido] penicillanate.
- 34. Phthalide 6[D(-).alpha.-amino-(p-hydroxy-phenylacetamido] penicillanate or a pharmaceutically acceptable acid addition salt thereof.
- 35. Phthalide 6[(hexahydro-1H-azepin-1-yl)-methyleneamino] penicillanate or a pharmaceutically acceptable acid addition salt thereof.
- 36. Phthalide 6-(N,N-dimethylformamidine-N.sup.1 -) penicillanate or a pharmaceutically acceptable acid addition salt thereof.
- 37. Phthalide 6[2,2-dimethyl-5-oxo-4-phenyl-1-imidazolidinyl] penicillanate.
Priority Claims (1)
Number |
Date |
Country |
Kind |
19604/71 |
Jun 1971 |
UK |
|
CROSS-REFERENCE
This is a continuation, of Ser. No. 524,776 filed Nov. 18, 1974 which is a continuation of Ser. No. 259,941, filed June 5, 1972, both now abandoned.
US Referenced Citations (5)
Foreign Referenced Citations (1)
Number |
Date |
Country |
1,377,661 |
Dec 1974 |
UK |
Continuations (2)
|
Number |
Date |
Country |
Parent |
524776 |
Nov 1974 |
|
Parent |
259941 |
Jun 1972 |
|